Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay

Journal of Clinical Microbiology

Volumn 41, Issue 8, 2003, Pages 3881-3884

  Rebucci, Chiara ^b   Cerino, Antonella ^a   Cividini, Agostino ^a,b   Timo, Letizia ^a   Furione, Milena ^c   Mondelli, Mario U ^a,b,d  

^a Lab di Ricerca Area Infettivologica   (Italy)

^b Ist di Clin delle Malat Infettive   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CORE PROTEIN; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; DEVICE; DRUG RESPONSE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; LIVER CELL; MALE; PRIORITY JOURNAL; RELAPSE; SERUM; TREATMENT FAILURE;

ANTIVIRAL AGENTS; DRUG MONITORING; HEPACIVIRUS; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOASSAY; RNA, VIRAL;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0041522313     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.8.3881-3884.2003     Document Type: Article

References (11)

1. Alberti, A., L. Chemello, and L. Benvegnù. 1999. Natural history of hepatitis C. J. Hepatol. 31(Suppl. 1):17-24.
2. Bouvier-Alias, M., K. Patel, H. Dahari, S. Beaucourt, P. Larderie, L. Blatt, C. Hezode, G. Picchio, D. Dhumeaux, A. U. Neumann, J. G. McHutchison, and J.-M. Pawlotsky. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36:211-218.
3. Cividini, A., C. Rebucci, E. Silini, and M. U. Mondelli. 2001. Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? Gastroenterology 121:1526-1527.
4. Cividini, A., A. Cerino, A. Muzzi, M. Furione, C. Rebucci, L. Segagli, M. Gatti, V. Barnaba, and M. U. Mondelli. 2003. Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C. J. Clin. Microbiol. 41:2144-2146.
5. Di Bisceglie, A. M., and J. H. Hoofnagle. 2002. Optimal therapy of hepatitis C. Hepatology 36:S121-S127.
6. Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Gonçales, D. Häussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
7. Knodell, R. G., K. G. Ishak, W. C. Black, T. S. Chen, R. Craig, N. Kaplowitz, T. W. Kiernan, and J. Wollman. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
8. Silini, E. M., F. Bono, A. Cerino, V. Piazza, E. Solcia, and M. U. Mondelli. 1993. Virological features of HCV infection in hemodialysis patients. J. Clin. Microbiol. 31:2913-2917.
9. Tanaka, E., C. Ohue, K. Aoyagi, K. Yamaguchi, S. Yagi, K. Kiyosawa, and H. J. Alter. 2000. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 32:388-393.
10. Tong, M. J., L. M. Blatt, J. G. McHutchison, R. L. Co, and A. Conrad. 1997. Prediction of response during interferon α 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology 26:1640-1645.
11. Zeuzem, S., J. H. Lee, A. Franke, B. Rüster, O. Prümmer, and G. Herrmann. 1998. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 27:1149-1156.